Beijing Tiantan Biological Products Corp Ltd

CN

BETIA

Health Care

28.94 ₽

Current price

Buy
28.94 ₽

Target price 00%

Ranks rating

76

  • Position in sub-industry

    95 / 1361

  • Position in country

    2236 / 7387

  • Return on Assets, %

    10.8

    -40.3

  • Net income margin, %

    29.5

    -180

  • EBITDA margin, %

    39.1

    -168.2

  • Debt to Equity, %

    1.6

    3.2

  • Intangible assets and goodwill, %

    8.6

    0.2

  • Revenue CAGR 3Y, %

    14.5

    12.5

  • Total Equity change 1Y, %

    8.5

    -9

  • Revenue Y, % chg

    15.8

    0

  • P/E

    40.6

    31

  • P/BV

    4.5

    1.8

  • P/S

    8.7

    10.3

  • EV/S

    8.7

    7.5

  • EV/EBITDA

    26.4

    -1.6

  • Average Analyst recommendation

    Buy

    Buy

  • Average upside forecasts, %

    15.2

    131.1

  • Forward P/E

    31.5

    21.4

  • Dividend Yield, %

    0.1

    1.1

  • Forward Dividend Yield, %

    0

    0.1

  • Expected dividend per share

    0

    0

  • Payout Ratio, %

    22.2

    0

Get an analytical review of this company

Competitors

Ranks

  • Imeik Technology Development Co Ltd

    00%

  • Chongqing Zhifei Biological Products Co Ltd

    00%

  • Shanghai RAAS Blood Products Co Ltd

    00%

  • Hualan Biological Engineering Inc

    00%

  • Beijing Tiantan Biological Products Corp Ltd

    00%

  • Sichuan Kelun-Biotech Biopharmaceutical Co Ltd

    00%

  • Akeso Inc

    00%

  • Gan & Lee Pharmaceuticals

    00%

  • Innovent Biologics Inc

    00%

  • Beijing Wantai Biological Pharmacy Enterprise Co Ltd

    00%

Ready-made portfolio of the best Russian stocks

  • Created by artificial intelligence
  • Verified by analysts
  • Available even to beginners

Company information

  • Country

    China

  • Sector

    Health Care

  • Industry group

    Pharmaceuticals, Biotechnology & Life Sciences

  • Industry

    Biotechnology

  • Sub-sector

    Health Care

  • Capitalization (millions of $)

    6236.2

  • Ticker

    600161.SS

  • ISIN

    CNE000000WF9

  • IPO date

    1998-06-16

  • Availability on Russian exchanges

    No

  • Reporting for

    2024-03-28

  • Date fact. publication of reports

    2023-12-31

Company Description

BEIJING TIANTAN BIOLOGICAL PRODUCTS CORPORATION LIMITED is a China-based company principally engaged in the biopharmaceutical businesses. The Company’s primary products include preventive products, blood products and other biological products, such as the influenza A (H1N1) vaccines (split, inactivated),hepatitis B vaccines, poliomyelitis vaccines, measles-mump-rubella (MMR) vaccines, encephalitis B vaccines, influenza vaccinations, bacterial vaccines, human serum albumin (HSA) and intravenous immunoglobulin (IVIG), among others. The Company mainly distributes its products within domestic markets and to Hong Kong markets.

A step towards better analytics

  • find the best promotions through the Screener
  • keep an eye on stock valuation
  • download detailed reports

and much more after free registration

Registration

More convenient from your phone? Download: